Literature DB >> 33912766

Natural Killer Cell Large Granular Lymphocyte Leukemia-Induced Glomerulonephritis.

Pierre Isnard1,2, Charel Linster3, Julie Bruneau1,2, Eric Thervet2,3, Jean-Paul Duong Van Huyen1,2, Julien Rossignol4, Alexandre Karras2,3, Sophie Chauvet2,3, Marion Rabant1,2.   

Abstract

Entities:  

Year:  2021        PMID: 33912766      PMCID: PMC8071643          DOI: 10.1016/j.ekir.2021.01.024

Source DB:  PubMed          Journal:  Kidney Int Rep        ISSN: 2468-0249


× No keyword cloud information.

Introduction

Large granular lymphocyte (LGL) leukemia are mature T cell and natural killer (NK) cell neoplasms that exhibit a chronic and clonal expansion of large granular lymphocytes in the peripheral blood. About one-third of patients are asymptomatic with an indolent clinical course. Clinicobiologic features are mainly characterized by cytopenias, splenomegaly, and by the frequent occurrence of various autoimmune diseases. Renal manifestations occurring in patients with LGL leukemia are rare and poorly described. They mainly involve indirect kidney damage related to dysimmune conditions, such as cryoglobulinemia-induced glomerulonephritis. To our knowledge, this case is the first report of a glomerulonephritis directly induced by circulating LGL from a NK cell lineage.

Case Presentation

A 78-year-old man was referred to our nephrology department for renal impairment and proteinuria. His medical history consisted of non–insulin-dependent type 2 diabetes with mild retinopathy and nephropathy associating microalbuminuria and normal kidney function, controlled hypertension, and dyslipidemia. He had no family history of hematologic, immune, or kidney disorders. The patient was diagnosed with an expanded clonal NK cell LGL population 3 years earlier, with a lymphocyte count of 16,000 cells/mm3, the presence of large lymphocytes containing typical azurophilic granules on blood smear, and flow cytometry analysis showing a CD2+/CD3−/CD4−/CD8−/CD56+/CD16+ phenotype. Because of the indolent evolution of this NK cell lymphoproliferation, therapeutic abstention was decided with a biologic follow-up every 6 months. Upon admission, the results of the physical examination were unremarkable, but laboratory investigations revealed rapidly progressive renal failure with increased serum creatinine (220 μmol/l vs. 170 μmol/l 6 months earlier and 80 μmol/l 1 year before the current admission to the renal unit). The urinary protein-to-creatinine ratio was 2 g/g and urinalysis revealed microscopic hematuria at 420 cells/mm3 together with sterile leukocyturia at 100 cells/mm3. Antinuclear antibodies, antineutrophilic cytoplasmic antibodies, and cryoglobulinemia were negative. Complement level and serum proteins electrophoresis were normal. Tests for HIV and hepatitis B and C viruses were negative. A hematologic analysis revealed persistent leukocytosis at 16,400 cells/mm3 with mild anemia at 10.5 g/dl, and normal neutrophil and platelet counts. Renal ultrasound and a computed tomography scan were performed upon admission and showed kidneys of preserved size and shape with a kidney length pole to pole of 110 mm on both the right and left kidneys. A kidney biopsy specimen was obtained for light microscopy and immunofluorescence analysis. The histologic analysis revealed diffuse glomerular lesions with mainly global endocapillary proliferation with marked predominance of mononuclear circulating cells (Figures 1a and 1b). The mesangial axes were discreetly thickened without cell proliferation and the glomerular basement membranes rarely showed a duplication appearance on silver staining without clear subendothelial deposits (Figure 1c). The tubulointerstitial compartment revealed interstitial edema with mononuclear cells infiltration, together with acute tubular necrosis lesions (Figures 1a and 1d). Moreover, numerous tubulitis lesions were seen (Figure 1d). Immunofluorescence analysis on glomeruli was negative for immunoglobulin A, immunoglobulin G, C1q, and fibrin staining. However, segmental and parietal immunoglobulin M (IgM), kappa, lambda, and C3 deposits were found on segmental glomerulosclerotic lesions. No renal amyloidosis was observed. According to the flow cytometry immunophenotyping of the patient’s NK cell lymphocytosis, immunohistochemistry (IHC) targeting CD2, CD3, CD4, CD7, CD8, granzyme B, and CD56 was performed on the kidney biopsy specimen (Figures 2a and 2b). Strikingly, IHC confirmed that the glomerular endocapillary infiltrating cells shared the same phenotype as the LGL NK cells (Figure 2b), suggesting that the circulating tumor cells were directly responsible for the endocapillary glomerulonephritis lesions. In addition, IHC also revealed that the inflammatory cells in the tubular wall responsible of tubulitis lesions also derived from the LGL NK cells (Figure 2c).
Figure 1

Light microscopy and immunofluorescence analysis. (a) Light microscopy using periodic acid–Schiff staining showing diffuse glomerular lesions with mainly global endocapillary proliferation composed of mononuclear circulating cells and interstitial edema with acute tubular necrosis lesions within the tubulointerstitial compartment (original magnification ×200). (b) Light microscopy using Masson Trichrome staining showing global endocapillary proliferation composed of mononuclear circulating cells (original magnification ×400). (c) Light microscopy using silver staining showing rare glomerular basement membrane double contours (red arrow; original magnification ×400). (d) Light microscopy using periodic acid–Schiff staining showing acute tubular necrosis with numerous tubulitis lesions (red arrow; original magnification ×200). Scale bar = 100 μm.

Figure 2

Flow cytometry and immunohistochemistry analysis. (a) Flow cytometry analysis on a blood sample with CD45+ cells gate analysis and CD2+/CD3− gate analysis showing a CD2+/CD3−/CD4−/CD5−/CD7+/CD8−/CD56+ phenotype. Green: positive marker; red: negative marker. (b) Immunohistochemistry analysis on a kidney biopsy specimen targeting CD2, CD3, CD7, CD8, granzyme B, and CD56 showing a CD2+/CD3−/CD7+/CD8−/CD56+/granzyme B+ phenotype of the infiltrating endocapillary glomerular cells (original magnification ×400). (c) Immunohistochemistry analysis on tubulointerstitial compartment targeting CD2 and granzyme B showing CD2+/granzyme B+ cells within tubular epithelium (original magnification ×200). Scale bar = 100 μm.

Light microscopy and immunofluorescence analysis. (a) Light microscopy using periodic acid–Schiff staining showing diffuse glomerular lesions with mainly global endocapillary proliferation composed of mononuclear circulating cells and interstitial edema with acute tubular necrosis lesions within the tubulointerstitial compartment (original magnification ×200). (b) Light microscopy using Masson Trichrome staining showing global endocapillary proliferation composed of mononuclear circulating cells (original magnification ×400). (c) Light microscopy using silver staining showing rare glomerular basement membrane double contours (red arrow; original magnification ×400). (d) Light microscopy using periodic acid–Schiff staining showing acute tubular necrosis with numerous tubulitis lesions (red arrow; original magnification ×200). Scale bar = 100 μm. Flow cytometry and immunohistochemistry analysis. (a) Flow cytometry analysis on a blood sample with CD45+ cells gate analysis and CD2+/CD3− gate analysis showing a CD2+/CD3−/CD4−/CD5−/CD7+/CD8−/CD56+ phenotype. Green: positive marker; red: negative marker. (b) Immunohistochemistry analysis on a kidney biopsy specimen targeting CD2, CD3, CD7, CD8, granzyme B, and CD56 showing a CD2+/CD3−/CD7+/CD8−/CD56+/granzyme B+ phenotype of the infiltrating endocapillary glomerular cells (original magnification ×400). (c) Immunohistochemistry analysis on tubulointerstitial compartment targeting CD2 and granzyme B showing CD2+/granzyme B+ cells within tubular epithelium (original magnification ×200). Scale bar = 100 μm.

Discussion

LGL leukemia are rare mature T cell and NK cell neoplasms. According to the 2016 World Health Organization classification, there are 3 subtypes of LGL leukemia: chronic T cell leukemia (85%), NK cell lymphocytosis (<10%), and aggressive NK cell leukemia (<5%). The first 2 entities are chronic and indolent diseases characterized by cytopenias and autoimmune conditions; the latter is a more aggressive neoplasm with a poor outcome. LGL leukemia principally affects elderly people with a median age of 60 years and clinical manifestations are mainly related to neutropenia-induced recurrent infections. Among autoimmune diseases associated with LGL leukemia, rheumatoid arthritis is the most common, occurring in ≤20% of patients. In our patient, the combination of lymphocytosis (16,000 cells/mm3), the presence of large lymphocytes containing typical azurophilic granules on blood smear, and flow cytometry analysis showing a CD3−/CD8−/CD16+/CD56+ phenotype led to the diagnosis of NK LGL leukemia. Renal manifestations occurring in LGL leukemia are rare and poorly described and mainly involve indirect kidney damage related to dysimmune conditions, such as renal amyloidosis. Of interest, Audemard et al. reported a series of 11 patients displaying LGL leukemia associated with vasculitis with 3 T cell LGL leukemia (28%) showing histopathologic evidence of membranoproliferative/endocapillary glomerulonephritis related to mixed type 2 cryoglobulinemia and the presence of a monoclonal IgM kappa. Unfortunately, no specific kidney histopathologic findings nor immunophenotyping results were reported. In our patient, the detection of IgM and C3 deposition by immunofluorescence analysis may suggest a diagnosis of cryoglobulinemia. However, no mesangial cell proliferation nor subendothelial deposits were seen and we failed to detect any cryoglobulin in patient’s blood samples. Moreover, the IgM and C3 immunofluorescent deposits were segmental and focal, more probably reflecting the fibrous segmental lesions. On the other hand, IHC staining confirmed in our patient that the glomerular endocapillary infiltrating cells shared the same phenotype as LGL NK cells (CD2+/CD3−/CD7+/CD8−/CD56+/granzyme B+). In the absence of electronic microscopy, we were not able to formally exclude early diabetic kidney lesions regarding the patient’s medical history of type 2 diabetes with microalbuminuria. Moreover, we could not exclude membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. However, in this rare condition, most patients (14/16) have paraprotein on serum immunofixation, which was not present in our patient. Of interest, renal B cell lymphoma involvement could also rarely present as an endocapillary glomerulonephritis with glomerular capillaries being occluded by intravascular lymphoma cells. Nevertheless, interstitial topography is observed in most of the kidney biopsy specimens. Of note, Christopoulos et al. reported a 65-year-old patient with acute renal failure the presence of T cell large granular lymphocytes (CD3+/CD8+/CD56−/CD57+) within the renal interstitium without glomerular involvement nor tubular involvement. In our case, IHC analysis also revealed that the tubulitis lesions were related to the leukemic NK cells.

Conclusion

To our knowledge, this current case is the first report of a direct glomerular detection by IHC of tumor lymphoid cells from LGL leukemia in a clinical and biologic context of glomerulonephritis. This report could also alert clinicians of this rare connection between LGL leukemia and endocapillary glomerulonephritis, which should prompt discussion of extensive lymphocyte immunophenotyping by IHC. Despite the indolent course of most cases of LGL leukemia that do not require a specific treatment, clinicians should be aware of this rare association that could lead to a clone-directed therapy that may improve renal outcome (Table 1).
Table 1

Teaching points

Renal manifestations occurring in large granular lymphocyte leukemia are rare and mainly involve indirect kidney damage, such as cryoglobulinemia.
First report of a direct glomerular detection by immunohistochemistry of tumor lymphoid cells from large granular lymphocyte leukemia in a clinical and biological context of glomerulonephritis.
Immunohistochemistry analysis also revealed that the leukemic natural killer cells were responsible for the tubulitis lesions observed on the kidney biopsy specimen.
This rare connection between large granular lymphocyte leukemia and endocapillary glomerulonephritis, should prompt discussion of extensive lymphocyte immunophenotyping by immunohistochemistry.
Despite the indolent course of most of the large granular lymphocyte leukemia that do not require a specific treatment, clinicians should be aware of this rare association that could lead to a clone-directed therapy that may improve renal outcome.
Teaching points

Disclosure

All the authors declared no competing interests.
  8 in total

1.  T-cell large granular lymphocyte leukemia presenting as end-stage renal disease: the diagnostic role of flow-cytometric and clonality analysis of the urine sediment.

Authors:  P D Christopoulos; S Katsoudas; A Androulaki; L Nakopoulou; T Economopoulos; D V Vlahakos
Journal:  Clin Nephrol       Date:  2009-02       Impact factor: 0.975

2.  A case report - renal heavy chain amyloidosis and T-cell large granular lymphocytic leukaemia.

Authors:  Julie Fu; Lisa Lee; Ping Zhou; Teresa Fogaren; Raymond Comenzo
Journal:  Amyloid       Date:  2019       Impact factor: 7.141

3.  Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.

Authors:  Milena Kohn; Alexandre Karras; Mohamad Zaidan; Charles Bénière; Jean-Baptiste de Fréminville; Kamel Laribi; Marie Claire Perrin; Marion Malphettes; Ronan Le Calloch; Bruno Anglaret; Juliana Martiniuc; Sarah Bailly; Sylvie Chevret; Thierry Molina; Eric Thervet; Catherine Thieblemont
Journal:  Leuk Lymphoma       Date:  2020-02-10

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 5.  LGL leukemia: from pathogenesis to treatment.

Authors:  Thierry Lamy; Aline Moignet; Thomas P Loughran
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

6.  Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases.

Authors:  Alexandra Audemard; Thierry Lamy; Benoît Bareau; Flore Sicre; Felipe Suarez; Florence Truquet; Véronique Salaun; Magaret Macro; Laurence Verneuil; Thierry Lobbedez; Cindy Castrale; Jonathan Boutemy; Stéphane Cheze; Loïk Geffray; Nicolas Schleinitz; Jérôme Rey; Estibaliz Lazaro; Loïc Guillevin; Boris Bienvenu
Journal:  Semin Arthritis Rheum       Date:  2013-12       Impact factor: 5.532

Review 7.  Lymphomas diagnosed by percutaneous kidney biopsy.

Authors:  Tom Törnroth; Maija Heiro; Niels Marcussen; Kaarle Franssila
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860

8.  Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.

Authors:  Christopher P Larsen; Nidia C Messias; Patrick D Walker; Mary E Fidler; Lynn D Cornell; Loren H Hernandez; Mariam P Alexander; Sanjeev Sethi; Samih H Nasr
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

  8 in total
  1 in total

1.  Case Report: Endocapillary Glomerulopathy Associated With Large Granular T Lymphocyte Leukemia.

Authors:  Tao Zhao; Nan Hu; Xiaojuan Yu; Tao Su
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.